A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors
Clinical trial NCT05258266 · UNKNOWN
Trial details
- NCT number
- NCT05258266
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2023-06-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.